目錄:MedChemExpress LLC>>信號通路>> SH5-07 | MedChemExpress
CAS | 1456632-41-9 | 純度 | ≥98.0% |
---|---|---|---|
分子量 | 625.61 | 分子式 | C??H??F?N?O?S |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 10 mM * 1 mL |
貨號 | HY-100494 | 應用領域 | 醫(yī)療衛(wèi)生,化工,生物產業(yè),制藥 |
MCE 的所有產品僅用作科學研究或藥證申報,我們不為任何個人用途提供產品和服務。
CAS No. : 1456632-41-9
MCE 國際站:SH5-07
產品活性:SH5-07 是一種基于異羥肟酸的 Stat3 抑制劑,在體外實驗中的 IC50 值為 3.9 μM。
研究領域:JAK/STAT Signaling | Stem Cell/Wnt
作用靶點:STAT
In Vitro: SH5-07 is a hydroxamic acid analog of BP-1-102. SH5-07 dose-dependently inhibits Stat3 activity with an IC50 of 3.9±0.6 μM in in vitro assay. It preferentially inhibits Stat3:Stat3 DNA-binding activity, ahead of inhibiting Stat1:Stat3 activity, with minimal effects on Stat1:Stat1 activity. SH5-07 binds Stat3, disrupts Stat3 association with growth factor receptor, and thereby inhibits Stat3 phosphorylation. It induces antitumor cell effects against malignant cells harboring constitutively-active Stat3. SH5-07 inhibits the expression of known Stat3-regulated genes. Bcl-2, Bcl-xL, c-Myc, Survivin, Cyclin D1 and Mcl-1 expression is reduced in response to 24 h, 5 μM SH5-07 treatment.
In Vivo: Tail vein injection or oral gavage delivery of SH5-07 or SH4-54 inhibits growth of 90-150 mm3 established subcutaneous mouse xenografts of human glioma (U251MG) and breast (MDA-MB-231) tumors that harbor aberrantly-active Stat3, associated with decreased c-Myc, Mcl-1 and Cyclin D1 expression. No significant changes in body weights, blood cell counts, or the gross anatomy of organs, or obvious signs of toxicity are observed.
相關產品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | JAK/STAT Compound Library | Kinase Inhibitor Library | Stem Cell Signaling Compound Library | Anti-Cancer Compound Library | Small Molecule Immuno-Oncology Compound Library | Anti-Aging Compound Library | Differentiation Inducing Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Blood Cancer Compound Library | Anti-Obesity Compound Library | Transcription Factor-Targeted Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Anti-Prostate Cancer Compound Library | Cancer Stem Cells Compound Library | Highly Selective Inhibitors Library | 8α-Tigloyloxyhirsutinolide 13-O-acetate | Stafia-1-dipivaloyloxymethyl ester | Niclosamide monohydrate | STAT6-IN-2 | 15-keto-Prostaglandin E2 | Brevilin A | STAT3 degrader-1 | NSC-370284 | Broussonin E | RO8191 | Eflepedocokin alfa | Morusin | STAT3-IN-13 | DG-8 | Antitumor agent-73 | 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-(4-cyanophenoxy)phenyl)urea | IST5-002 | JAK-STAT-IN-1 | Delphinidin chloride | SC-43 | Astaxanthin | LLL12 | MNK8 | Syk-IN-6 | STAT5-IN-2 | (+)-Ochromycinone | STAT3-IN-11 | HP590 | FLLL32 | SI-109
熱門產品線:重組蛋白 | 化合物庫 | 天然產物 | 熒光染料 | PROTAC | 同位素標記物 | 寡核苷酸 | 抗體 | 點擊化學
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry